Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis A Farraye

Showing results (231-240 of 431) with videos related to

Pageof 44
Sort By:
Clinical and Translational Gastroenterology|March 27, 2025
Patients With Inflammatory Bowel Disease Are at Increased Risk of Respiratory Syncytial Virus Infections After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Propensity-Matched Cohort AnalysisSaqr Alsakarneh, Oscar Ramirez Ramirez, Mary S Hayney, et al.
Inflammatory Bowel Diseases|December 1, 2021
Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysisAthanasios Desalermos, Michael Pimienta, Markos Kalligeros, et al.
Inflammatory Bowel Diseases|October 31, 2024
Comparative Effectiveness of Ozanimod and Vedolizumab as First-Line Advanced Therapies in Ulcerative Colitis: A Propensity-Matched Cohort AnalysisGursimran S Kochhar, Himsikhar Khataniar, Jana G Hashash, et al.
Alimentary Pharmacology & Therapeutics|June 28, 2024
Use of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel diseaseAakash Desai, Jessica Petrov, Jana G Hashash, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 18, 2006
Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosisKleanthis G Dendrinos, James M Becker, Arthur F Stucchi, et al.
Inflammatory Bowel Diseases|May 21, 2005
Crohn's disease after gastric bypass surgery for morbid obesity: is there an association?Lynne B Ahn, Christopher S Huang, R Armour Forse, et al.
Alimentary Pharmacology & Therapeutics|March 10, 2023
Cost-effectiveness of an adjuvanted recombinant zoster vaccine in adults with inflammatory bowel diseaseFreddy Caldera, Aaron C Spaulding, Bijan Borah, et al.
Digestive Diseases and Sciences|January 10, 2026
Pneumococcal Vaccine Is Associated with Improved Outcomes in Inflammatory Bowel Disease: Insights from a Propensity-Matched Study in the United StatesMouhand F H Mohamed, Sapana R Gupta, Azizullah Beran, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 13, 2025
Measles Outbreaks 2025 and Beyond: Implications for Immunosuppressed Patients Managed by Gastroenterologists and HepatologistsFreddy Caldera, James H Conway, Michael J Scolarici, et al.
Inflammatory Bowel Diseases|March 13, 2013
Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel diseaseMillie D Long, Francis A Farraye, Philip N Okafor, et al.
Pageof 44

Showing results (231-240 of 431) with videos related to

Sort By:
Pageof 44
Clinical and Translational Gastroenterology|March 27, 2025
Patients With Inflammatory Bowel Disease Are at Increased Risk of Respiratory Syncytial Virus Infections After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Propensity-Matched Cohort AnalysisSaqr Alsakarneh, Oscar Ramirez Ramirez, Mary S Hayney, et al.
Inflammatory Bowel Diseases|December 1, 2021
Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysisAthanasios Desalermos, Michael Pimienta, Markos Kalligeros, et al.
Inflammatory Bowel Diseases|October 31, 2024
Comparative Effectiveness of Ozanimod and Vedolizumab as First-Line Advanced Therapies in Ulcerative Colitis: A Propensity-Matched Cohort AnalysisGursimran S Kochhar, Himsikhar Khataniar, Jana G Hashash, et al.
Alimentary Pharmacology & Therapeutics|June 28, 2024
Use of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel diseaseAakash Desai, Jessica Petrov, Jana G Hashash, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 18, 2006
Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosisKleanthis G Dendrinos, James M Becker, Arthur F Stucchi, et al.
Inflammatory Bowel Diseases|May 21, 2005
Crohn's disease after gastric bypass surgery for morbid obesity: is there an association?Lynne B Ahn, Christopher S Huang, R Armour Forse, et al.
Alimentary Pharmacology & Therapeutics|March 10, 2023
Cost-effectiveness of an adjuvanted recombinant zoster vaccine in adults with inflammatory bowel diseaseFreddy Caldera, Aaron C Spaulding, Bijan Borah, et al.
Digestive Diseases and Sciences|January 10, 2026
Pneumococcal Vaccine Is Associated with Improved Outcomes in Inflammatory Bowel Disease: Insights from a Propensity-Matched Study in the United StatesMouhand F H Mohamed, Sapana R Gupta, Azizullah Beran, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 13, 2025
Measles Outbreaks 2025 and Beyond: Implications for Immunosuppressed Patients Managed by Gastroenterologists and HepatologistsFreddy Caldera, James H Conway, Michael J Scolarici, et al.
Inflammatory Bowel Diseases|March 13, 2013
Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel diseaseMillie D Long, Francis A Farraye, Philip N Okafor, et al.
Pageof 44